Drug Shortage Report for CUVITRU

Last updated on 2019-08-24 History
Report ID 82602
Drug Identification Number 02461692
Brand name CUVITRU
Common or Proper name Immune globulin Subcutaneous 20%
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) IMMUNOGLOBULIN
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1g, 2g,4g and 8g
ATC code J06BA
ATC description IMMUNOGLOBULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-04-09
Actual start date 2019-05-09
Estimated end date 2019-09-30
Actual end date 2019-08-23
Shortage status Resolved
Updated date 2019-08-24
Company comments Shortage resolved on 2019-08-23
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-08-24 English Compare
v7 2019-08-23 French Compare
v6 2019-08-23 English Compare
v5 2019-05-10 English Compare
v4 2019-05-08 French Compare
v3 2019-05-08 English Compare
v2 2019-04-29 French Compare
v1 2019-04-29 English Compare

Showing 1 to 8 of 8